|
|
Subscribe
to our newsletter:
| |
|
|
|
|
Search results for: kine
6 - 10 of 13 <<previous | next>>
Drugs results:
|
Avandamet, a combination of Rosiglitazone and Metformin, is used to treat high blood sugar that is caused by Type 2 Diabetes. Rosiglitazone helps your body use insulin better and it reduces the actual amount of insulin in your body. Metformin reduces the more...
|
|
Also known as Metformin, Glucophage is used to treat a type of diabetes called Type 2 Diabetes. Insulin produced by the pancreas of patients with Type 2 Diabetes is not able to get sugar into the cells of the body where it can work properly. Using Glucoph more...
|
|
Glucotrol XL, also known as Glipizide is used to treat a type of diabetes called Type 2 Diabetes. It is part of a group of medicines called Sulfonylureas that help insulin get into the cells where it can work properly to lower blood sugar.
Be sure to more...
|
|
Glyburide is used to treat a type of diabetes called Type 2 Diabetes. It is part of a group of medicines called Sulfonylureas that help insulin get into the cells where it can work properly to lower blood sugar.
Be sure to tell your doctor of any all more...
|
|
Insulin is one of many hormones that occur naturally in the body. After eating, insulin works by causing sugar to leave the blood into our cells to make fat, sugar, and protein, and by helping us use the fat, sugar, and protein that we have more...
|
Diseases results:Diabetes
Insulin resistance
CachexiaArticles results:
| GPhA Rebuttal On Dr. Siegel's Comments At Hearing |
At the March 8, 2007 hearing before the Senate Health, Education, Labor and PensionsCommittee, Dr. Jay Siegel made some statements which merit a response to set the recordstraight. Siegel Statement: "there will always be a need for appropriate pre-marketing clinicaldata to ensure that a follow-on biologic is safe and effective"-- Siegel sees the need for pre-marketing clinical data for generics, but not forbrands.
|
| FDA To Consider Approval Of First CCR5 Antagonist Against HIV/AIDS |
An advisory panel of the US Food and Drug Administration (FDA) is meeting tomorrow to decide whether to recommend approval of Pfizer's HIV/AIDS drug Maraviroc for patients already taking other drugs. If approved, it will be the first drug available in the class called CCR5 antagonists.The FDA does not have to follow the panel's recommedations, but it usually does.Many HIV drugs fight the virus from inside infected white blood cells.
|
| Positive Pharmacokinetic Study Results Presented By Alpharma |
Alpharma Inc.(NYSE: ALO), a leading global specialty pharmaceutical company through its Pharmaceuticals Division, this week presented positive results of a pharmacokinetic study of its investigational abuse-deterrent, extended-release opioid at the 26th annual scientific meeting of the American Pain Society in Washington, D.C.
|
| Manchester Researcher Wins Libyan Award |
Abdul Gbaj, who is researching the pharmaceutical aspects of genetic and tumour sciences at the University's School of Pharmacy and Pharmaceutical Sciences, received his award from the Libyan Minister of Higher Education, Dr Akeel Hussain Akeel."When he told me I had won this award, I was very proud. There are 5,000 Libyan Masters and PhD students across the globe, 1,600 of them in the UK," Abdul said."I was very lucky to come to Manchester.
|
6 - 10 of 13 <<previous | next>>
|
|
|
